SCHEMBL27670848

SCHEMBL27670848

CCn1cnc2c(=O)n(-c3ccc(Cl)c(C(C)C)c3)c(SCCC(F)(F)F)nc21

nearest known ligand 0.34

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SRC P12931 2/20 0.32
APLNR P35414 1/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
CTSS P25774 1/20 0.32
CTSK P43235 1/20 0.32
ALDH1A2 O94788 2/20 0.31
ALDH1A3 P47895 2/20 0.31
ALDH1A1 P00352 1/20 0.31
DDR1 Q08345 1/20 0.31
TGM2 P21980 1/20 0.31
TDP1 Q9NUW8 1/20 0.30
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5440474 0.88 CCR1 (0.33) APLNRMEN1KMT2ACTSSCTSK
SCHEMBL5438652 0.88 CTSS (0.39) APLNRMEN1KMT2ACTSSCTSK
SCHEMBL5431917 0.85 CNR1 (0.39) ALDH1A2ALDH1A3TDP1TP53
SCHEMBL5432034 0.82 NPSR1 (0.41) MEN1KMT2AALDH1A1TP53
SCHEMBL5434559 0.81 MAOA (0.39) ALDH1A2ALDH1A3
SCHEMBL5433744 0.80 CTSS (0.38) MEN1KMT2ACTSSCTSKALDH1A2
SCHEMBL5426635 0.79 CYP2C19 (0.43) ALDH1A2ALDH1A3
SCHEMBL5431789 0.78 GRM1 (0.36) MEN1KMT2AALDH1A2ALDH1A3ALDH1A1
SCHEMBL5431688 0.78 MEN1 (0.33) APLNRMEN1KMT2ACTSSALDH1A2
SCHEMBL5796377 0.77 CYP2C19 (0.43) ALDH1A2ALDH1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1902201-A Bicyclic pyrimidin-4-(3H)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (VR1) MERCK SHARP & DOHME (GB) 2007-01-24 CN claimed
CN-1902201-A Bicyclic pyrimidin-4-(3H)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (VR1) MERCK SHARP & DOHME (GB) 2007-01-24 CN disclosed